Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients

References

• Suarez-Fueyo A, Bradley SJ, Klatzmann D, et al. T cells and autoimmune kidney disease. Nat Rev Nephrol. 2017;13(6):329–343.
   PubMed Web of Science ®Google Scholar
• Devarapu SK, Lorenz G, Kulkarni OP, et al. Cellular and molecular mechanisms of autoimmunity and lupus nephritis. Int Rev Cell Mol Biol. 2017;332:43–154.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680–1691.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy MM, Hogan SL, Poulton CJ, et al. Temporal and demographic trends in glomerular disease epidemiology in the Southeastern United States, 1986–2015. Clin J Am Soc Nephrol. 2017;12(4):614–623.
   PubMed Web of Science ®Google Scholar
• Alarcon GS. Multiethnic lupus cohorts: what have they taught us? Reumatol Clin. 2011;7(1):3–6.
   PubMedGoogle Scholar
• Mohammad AJ, Segelmark M. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis. J Rheumatol. 2014;41(7):1366–1373.
   PubMed Web of Science ®Google Scholar
• Group KDIGOKGW. KDIGO clinical practice guideline for glomerulonephritis[J]. Kidney Int Suppl. 2012. 2012;2(2):139–274.
   Google Scholar
• Hellmich B, Flossmann O, Gross WL, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007;66(5):605–617.
   PubMed Web of Science ®Google Scholar
• Rimes-Stigare C, Frumento P, Bottai M, et al. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease. Crit Care. 2015;19(1):383.
   PubMedGoogle Scholar
• Faurschou M, Dreyer L, Kamper AL, et al. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res. 2010;62(6):873–880.
   Web of Science ®Google Scholar
• Weidner S, Geuss S, Hafezi-Rachti S, et al. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004;19(6):1403–1411.
   PubMed Web of Science ®Google Scholar
• Doria A, Iaccarino L, Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006;119(8):700–706.
   PubMed Web of Science ®Google Scholar
• Liu P, Tan HZ, Li H, et al. Infections in hospitalized lupus nephritis patients: characteristics, risk factors, and outcomes. Lupus. 2018;27(7):1150–1158.
   PubMed Web of Science ®Google Scholar
• Feldman CH, Hiraki LT, Winkelmayer WC, et al. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015;67(6):1577–1585.
   PubMed Web of Science ®Google Scholar
• Demiselle J, Auchabie J, Beloncle F, et al. Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study. Ann Intensive Care. 2017;7(1):39.
   PubMedGoogle Scholar
• La-Crette J, Royle J, Lanyon PC, et al. Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis. Clin Rheumatol. 2018;37(4):1085–1090.
   PubMed Web of Science ®Google Scholar
• Mohammad AJ, Segelmark M, Smith R, et al. Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol. 2017;44(10):1468–1475.
   PubMed Web of Science ®Google Scholar
• Qian J, Li M, Zhang X, et al. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J. 2019;53(2):1800081.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725–1725.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–192.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Feeney ME, Thompson M, Gerlach AT, et al. Evaluation of rectal vancomycin irrigation for treatment of clostridioides difficile infection in patients post-colectomy for toxic colitis. Surg Infect (Larchmt). 2019;20(5):411–415.
   PubMed Web of Science ®Google Scholar
• Goupil R, Brachemi S, Nadeau-Fredette AC, et al. Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clin J Am Soc Nephrol. 2013;8(3):416–423.
   PubMed Web of Science ®Google Scholar
• Dalrymple LS, Katz R, Kestenbaum B, et al. The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis. 2012;59(3):356–363.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Robicsek A, Scranton R, et al. Veteran’s affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol. 2007;60(4):397–409.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Caster DJ, Cattran DC, et al. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95(2):281–295.
   PubMedGoogle Scholar
• Thong KM, Chan TM. Infectious complications in lupus nephritis treatment: a systematic review and meta-analysis. Lupus. 2019;28(3):334–346.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Hussain F, Iban D, et al. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002;11(4):234–239.
   PubMed Web of Science ®Google Scholar
• Kitagawa K, Furuichi K, Sagara A, et al. Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis. Clin Exp Nephrol. 2016;20(5):703–711.
   PubMed Web of Science ®Google Scholar
• McGregor JG, Negrete-Lopez R, Poulton CJ, et al. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrol Dial Transplant. 2015;30(Suppl. 1):i171–i181.
   PubMedGoogle Scholar
• Navarro-Zarza JE, Alvarez-Hernandez E, Casasola-Vargas JC, et al. Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus. 2010;19(1):43–48.
   PubMed Web of Science ®Google Scholar
• Lee J, Dhillon N, Pope J. All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford). 2013;52(5):905–909.
   PubMed Web of Science ®Google Scholar
• Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol. 1992;19(10):1559–1565.
   PubMed Web of Science ®Google Scholar
• Hou C, Jin O, Zhang X. Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus. Clin Rheumatol. 2018;37(10):2699–2705.
   PubMed Web of Science ®Google Scholar
• Xu PC, Tong ZY, Chen T, et al. Hypoalbuminaemia in antineutrophil cytoplasmic antibody-associated vasculitis: incidence and significance. Clin Exp Rheumatol. 2018;36(4):603–611.
   PubMed Web of Science ®Google Scholar
• Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31–42.
   PubMedGoogle Scholar
• Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–1657.
   PubMed Web of Science ®Google Scholar
• McLean RH, Forsgren A, Bjorksten B, et al. Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res. 1977;11(8):910–916.
   PubMed Web of Science ®Google Scholar
• Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157–176.
   PubMed Web of Science ®Google Scholar
• Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis. 2006;13(3):199–204.
   PubMed Web of Science ®Google Scholar
• Mouton CP, Bazaldua OV, Pierce B, et al. Common infections in older adults. Health Care Food Nutr Focus. 2001;18(3):1, 3–7.
   PubMedGoogle Scholar
• Carey IM, Critchley JA, DeWilde S, et al. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41(3):513–521.
   PubMed Web of Science ®Google Scholar
• Bartelink ML, Hoek L, Freriks JP, et al. Infections in patients with type 2 diabetes in general practice. Diabetes Res Clin Pract. 1998;40(1):15–19.
   PubMed Web of Science ®Google Scholar